Wei Chen

11.6k citations

272 papers · 8.2k indexed · 1 hit paper · h-index 47

Impact in

Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Oncology top 1%
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments

Papers in ⓘ

Immunology and Allergy 22
- Cell Adhesion Molecules Research 19
Cancer Research 50
- MicroRNA in disease regulation 14
- Cancer-related molecular mechanisms research 14
- Cancer, Lipids, and Metabolism 9

Co-authors: Fazlul H. Sarkar (7 shared papers)Seema Sethi (9 shared papers)Cheng Zhu (5 shared papers)Jizhong Lou (4 shared papers)Daniel J. Sargent (4 shared papers)Sharlene Gill (1 shared paper)Charles L. Loprinzi (1 shared paper)Stephan D. Thomé (1 shared paper)
Journals: Cancer Research (10 papers)PLoS ONE (8 papers)Journal of Clinical Oncology (7 papers)Journal of Thoracic Oncology (6 papers)Scientific Reports (6 papers)
Partner nations: China United States United Kingdom

In The Last Decade

Wei Chen

253 papers receiving 8.1k citations

Hit Papers

align trajectories log scale

Pooled Analysis of Fluorouracil-Based Adjuvant Therapy for Stage II and III Colon Cancer: Who Benefits and by How Much? 2004 · 756 citations

Peers

Countries citing papers authored by Wei Chen

Since Specialization

Citations

This map shows the geographic impact of Wei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Chen more than expected).

Fields of papers citing papers by Wei Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Chen. The network helps show where Wei Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Wei Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wei Chen Line = papers co-authored together Wei Chen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 272 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Pooled Analysis of Fluorouracil-Based Adjuvant Therapy for Stage II and III Colon Cancer: Who Benefits and by How Much? Journal of Clinical Oncology ·Sharlene Gill, Charles L. Loprinzi, Daniel J. Sargent, Stephan D. Thomé, Steven R. Alberts, Daniel G. Haller, Jacqueline Benedetti, Guido Francini, Lois E. Shepherd, Jean François Seitz, Roberto Labianca, Wei Chen, S. Stephen, Michael P. Heldebrant, Richard M. Goldberg Hit paper breakdown →	2004	756
2	Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer. PubMed ·Mary L. Disis, Emanuel Calenoff, Graham McLaughlin, Ann Murphy, Wei Chen, Bernd Groner, Margit Jeschke, Nick Lydon, Elaine McGlynn, Robert B. Livingston	1994	390
3	Leukocyte Telomere Dynamics: Longitudinal Findings Among Young Adults in the Bogalusa Heart Study American Journal of Epidemiology ·Ariel Aviv, Wei Chen, Jonathan P. Gardner, Minoru Kimura, Michael Brimacombe, Xiaojian Cao, S R Srinivasan, Gerald S. Berenson	2008	243
4	A nonsynonymous functional variant in integrin-αM (encoded by ITGAM) is associated with systemic lupus erythematosus Nature Genetics ·Swapan K. Nath, Shizhong Han, Xana Kim-Howard, Jennifer A. Kelly, Parvathi Viswanathan, Gary S. Gilkeson, Wei Chen, Cheng Zhu, Rodger P. McEver, Robert P. Kimberly, Marta E. Alarcón‐Riquelme, Timothy J. Vyse, Quan Zhen Li, Edward K. Wakeland, Joan T. Merrill, Judith A. James, Kenneth M. Kaufman, Joel M. Guthridge, John B. Harley	2008	219
5	Expression of neural BC200 RNA in human tumours The Journal of Pathology ·Wei Chen, W. Böcker, Jürgen Brosius, Henri Tiedge	1997	169
6	Loss of Let-7 Up-Regulates EZH2 in Prostate Cancer Consistent with the Acquisition of Cancer Stem Cell Signatures That Are Attenuated by BR-DIM PLoS ONE ·Dejuan Kong, Elisabeth I. Heath, Wei Chen, Michael L. Cher, Isaac J. Powell, Lance K. Heilbrun, Yiwei Li, Shadan Ali, Seema Sethi, Oudai Hassan, Clara Hwang, Nilesh Gupta, Dhananjay Chitale, Wael Sakr, Mani Menon, Fazlul H. Sarkar	2012	167
7	Phosphoglucose Isomerase/Autocrine Motility Factor Mediates Epithelial-Mesenchymal Transition Regulated by miR-200 in Breast Cancer Cells Cancer Research ·Aamir Ahmad, Amro Aboukameel, Dejuan Kong, Zhiwei Wang, Seema Sethi, Wei Chen, Fazlul H. Sarkar, Avraham Raz	2011	167
8	Forcing Switch from Short- to Intermediate- and Long-lived States of the αA Domain Generates LFA-1/ICAM-1 Catch Bonds Journal of Biological Chemistry ·Wei Chen, Jizhong Lou, Cheng Zhu	2010	157
9	Phase II Study of Maintenance Pembrolizumab in Patients with Extensive-Stage Small Cell Lung Cancer (SCLC) Journal of Thoracic Oncology ·Shirish M. Gadgeel, Nathan A. Pennell, Mary J. Fidler, Balázs Halmos, Philip Bonomi, James Stevenson, Bryan J. Schneider, Ammar Sukari, Jaclyn Ventimiglia, Wei Chen, Cathy Galasso, Antoinette J. Wozniak, Julie L. Boerner, Gregory P. Kalemkerian	2018	155
10	Molecular signature of epithelial-mesenchymal transition (EMT) in human prostate cancer bone metastasis. PubMed ·Seema Sethi, Jill A. Macoska, Wei Chen, Fazlul H. Sarkar	2010	149
11	Identification of the elementary structural units of the DNA damage response Nature Communications ·Francesco Natale, Alexander Rapp, Wei Yu, Andreas Maiser, Hartmann Harz, A. Scholl, Stephan Grulich, Tobias Anton, David Hörl, Wei Chen, Marco Durante, G. Taucher-Scholz, Heinrich Leonhardt, M. Cristina Cardoso	2017	146
12	Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer. PubMed ·Shadan Ali, Khaldoun Almhanna, Wei Chen, Philip A. Philip, Fazlul H. Sarkar	2010	145
13	Activation of the TXNIP/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: a novel inhibitory effect of minocycline Inflammation Research ·Wei Chen, Minjie Zhao, Shuzhi Zhao, Qianyi Lu, Lisha Ni, Chen Zou, Li Lu, Xun Xu, Huaijin Guan, Zhi Zheng, Qinghua Qiu	2016	143
14	B7-H3 is Overexpressed in Patients Suffering Osteosarcoma and Associated with Tumor Aggressiveness and Metastasis PLoS ONE ·Ling Wang, Qi Zhang, Wei Chen, Baoen Shan, YANG DING, Guochuan Zhang, Nana Cao, Lei Liu, Yingze Zhang	2013	140
15	Randomized trial comparing the effects of gliclazide, liraglutide, and metformin on diabetes with non‐alcoholic fatty liver disease Journal of Diabetes ·Wenhuan Feng, Caixia Gao, Yan Bi, Min Wu, Ping Li, Shanmei Shen, Wei Chen, Tingting Yin, Dalong Zhu	2017	122
16	EGCG inhibited bladder cancer SW780 cell proliferation and migration both in vitro and in vivo via down-regulation of NF-κB and MMP-9 The Journal of Nutritional Biochemistry ·Ke-Wang Luo, Wei Chen, Wing-Yin Lung, Xia-Yun Wei, Bao‐Hui Cheng, Zhiming Cai, Weiren Huang	2016	112
17	Randomized International Phase III Trial of ERCC1 and RRM1 Expression–Based Chemotherapy Versus Gemcitabine/Carboplatin in Advanced Non–Small-Cell Lung Cancer Journal of Clinical Oncology ·Gerold Bepler, Charles C. Williams, Michael J. Schell, Wei Chen, Zhong Zheng, George R. Simon, Shirish M. Gadgeel, Xiuhua Zhao, Fred Schreiber, Julie R. Brahmer, Alberto Chiappori, Tawee Tanvetyanon, Mary Pinder-Schenck, Jhanelle E. Gray, Eric B. Haura, Scott Antonia, Juergen R. Fischer	2013	108
18	The Dual PI3K/mTOR Inhibitor NVP-BEZ235 Induces Tumor Regression in a Genetically Engineered Mouse Model of PIK3CA Wild-Type Colorectal Cancer PLoS ONE ·Jatin Roper, Michael P. Richardson, Wei Vivian Wang, Larissa Georgeon Richard, Wei Chen, Erin M. Coffee, Mark J. Sinnamon, Lydia Lee, Peng‐Chieh Chen, Roderick T. Bronson, Eric S. Martin, Kenneth E. Hung	2011	106
19	Coproporphyrins I and III as Functional Markers of OATP1B Activity: In Vitro and In Vivo Evaluation in Preclinical Species Journal of Pharmacology and Experimental Therapeutics ·Hong Shen, Jungui Dai, T. Liu, Yaofeng Cheng, Wei Chen, Chris Freeden, Yusheng Zhang, W. Griffith Humphreys, P. Marathe, Yurong Lai	2016	104
20	FDA Approval of Palbociclib in Combination with Fulvestrant for the Treatment of Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer Clinical Cancer Research ·Amanda J. Walker, Suparna Wedam, Laleh Amiri‐Kordestani, Erik Bloomquist, Shengui Tang, Rajeshwari Sridhara, Wei Chen, Todd R. Palmby, Jeanne Fourie Zirkelbach, Wentao Fu, Qi Liu, Amy Tilley, Geoffrey Kim, Paul G. Kluetz, Amy E. McKee, Richard Pazdur	2016	104

About Wei Chen

Wei Chen is a scholar working on Immunology and Allergy, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 272 papers that have together received 8.2k indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (19 papers), Lung Cancer Treatments and Mutations (17 papers), MicroRNA in disease regulation (14 papers), Cancer-related molecular mechanisms research (14 papers), Prostate Cancer Treatment and Research (11 papers), Epigenetics and DNA Methylation (10 papers), Lung Cancer Research Studies (10 papers) and Cancer, Lipids, and Metabolism (9 papers). The work is most often cited by research in Cancer Research (1.6k citations), Oncology (2.4k citations), Aging (97 citations), Molecular Biology (3.6k citations) and Immunology (1.1k citations). Wei Chen has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Fazlul H. Sarkar, Seema Sethi, Cheng Zhu, Jizhong Lou, Daniel J. Sargent, Sharlene Gill, Charles L. Loprinzi, Stephan D. Thomé, Roberto Labianca and Jean François Seitz. Their work appears in journals such as Cancer Research, PLoS ONE, Journal of Clinical Oncology, Journal of Thoracic Oncology and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact